Fennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Chris Anigeron Rallis sold 1,186 shares of the business's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of C$9.68, for a total value of C$11,485.70.
Fennec Pharmaceuticals Stock Up 3.3 %
Shares of TSE FRX traded up C$0.31 on Tuesday, hitting C$9.80. The company had a trading volume of 1,012 shares, compared to its average volume of 1,947. The firm has a market capitalization of C$188.99 million, a P/E ratio of -166.01 and a beta of 0.25. The company has a quick ratio of 10.17, a current ratio of 7.80 and a debt-to-equity ratio of -620.83. Fennec Pharmaceuticals Inc. has a 12-month low of C$5.65 and a 12-month high of C$15.20. The business has a 50 day moving average of C$8.93 and a two-hundred day moving average of C$7.72.
Wall Street Analysts Forecast Growth
Separately, Stephens upgraded shares of Fennec Pharmaceuticals to a "strong-buy" rating in a report on Monday, November 18th.
View Our Latest Report on FRX
About Fennec Pharmaceuticals
(
Get Free Report)
Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.
Read More
Before you consider Fennec Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fennec Pharmaceuticals wasn't on the list.
While Fennec Pharmaceuticals currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
